Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Get email alerts on the Public Health Preparedness topic

No spam. Unsubscribe anytime.

Public health flags Super Bowl/FIFA planning and new FDA COVID vaccine policy as emerging concerns

3467124 · April 17, 2025
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

Public Health reported preparations for Super Bowl 60 and the FIFA World Cup and raised concerns about a recent FDA decision on seasonal COVID vaccine approvals that may limit availability and require placebo‑controlled trials for broader authorizations.

Dr. Runnan, representing the Public Health Department, told the committee the department has begun coordinating with law enforcement, environmental health and health care partners on health risks tied to large events coming to the region, including Super Bowl 60 and the FIFA World Cup in early 2026. He said the county is concerned about risks that could arise days before or after events, including measles or mosquito‑borne pathogens introduced by international travelers.

Dr. Runnan also flagged an administrative change at the federal level regarding seasonal COVID vaccines. He said the new FDA leadership published an opinion piece and issued recommendations that would limit seasonal COVID vaccine recommendations primarily to people 65 and older and certain high‑risk groups and that the FDA had suggested a requirement that vaccine providers seeking broader authorizations run placebo‑controlled trials—an unusual step given existing vaccines. "The scientific process was skipped," he said, adding the county will monitor effects on vaccine availability, authorization and insurance coverage and that the department is prepared to analyze the implications locally.

The committee asked public health to continue monitoring both the large‑events planning and federal vaccine policy developments and to report back as needed.